Low prevalence of testing for apolipoprotein B and lipoprotein (a) in the real world

• Asıl Yazarlar: Dana J Murdock (Yazar), Keran Moll (Yazar), Robert J Sanchez (Yazar), Jing Gu (Yazar), Sergio Fazio (Yazar), Gregory P Geba (Yazar), Fatima Rodriguez (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Elsevier, 2024-09-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Objective: Apolipoprotein B (ApoB) and lipoprotein (a) (Lp[a]) are predictors of cardiovascular disease (CVD) risk; therefore, current recommendations for CVD risk assessment and management advocate that patients receive testing for ApoB and Lp(a) in addition to the standard lipid panel. However, US...